Arcadia Biosciences (RKDA) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Arcadia Biosciences (RKDA) over the last 6 years, with Q3 2025 value amounting to $0.62.
- Arcadia Biosciences' EPS (Weighted Average and Diluted) rose 15254.24% to $0.62 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.73, marking a year-over-year decrease of 418.99%. This contributed to the annual value of -$2.0 for FY2024, which is 8232.16% up from last year.
- Per Arcadia Biosciences' latest filing, its EPS (Weighted Average and Diluted) stood at $0.62 for Q3 2025, which was up 15254.24% from -$3.26 recorded in Q2 2025.
- In the past 5 years, Arcadia Biosciences' EPS (Weighted Average and Diluted) ranged from a high of $2.33 in Q2 2023 and a low of -$27.3 during Q4 2021
- For the 5-year period, Arcadia Biosciences' EPS (Weighted Average and Diluted) averaged around -$3.36, with its median value being -$1.78 (2024).
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first plummeted by 745454.55% in 2022, then soared by 20674.16% in 2025.
- Arcadia Biosciences' EPS (Weighted Average and Diluted) (Quarter) stood at -$27.3 in 2021, then soared by 92.98% to -$1.92 in 2022, then fell by 3.38% to -$1.98 in 2023, then surged by 99.0% to -$0.02 in 2024, then soared by 3230.55% to $0.62 in 2025.
- Its EPS (Weighted Average and Diluted) stands at $0.62 for Q3 2025, versus -$3.26 for Q2 2025 and $1.9 for Q1 2025.